|
PIGM expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.07670000004667E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.394600E-04 |
| Normal-vs-Stage2 |
3.420100E-02 |
| Normal-vs-Stage3 |
3.0843999998531E-07 |
| Normal-vs-Stage4 |
3.59349999756731E-08 |
| Stage1-vs-Stage2 |
9.081800E-01 |
| Stage1-vs-Stage3 |
6.924100E-03 |
| Stage1-vs-Stage4 |
2.157900E-04 |
| Stage2-vs-Stage3 |
1.256820E-01 |
| Stage2-vs-Stage4 |
3.912100E-02 |
| Stage3-vs-Stage4 |
3.868600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.05099999997616E-06 |
| Normal-vs-AfricanAmerican |
2.02849999999533E-05 |
| Normal-vs-Asian |
2.761400E-01 |
| Caucasian-vs-AfricanAmerican |
1.638840E-01 |
| Caucasian-vs-Asian |
6.715000E-01 |
| AfricanAmerican-vs-Asian |
3.243400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.600400003278E-08 |
| Normal-vs-Female |
1.699200E-03 |
| Male-vs-Female |
6.123100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.448300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.162050E-04 |
| Normal-vs-Age(61-80Yrs) |
3.54760000043086E-07 |
| Normal-vs-Age(81-100Yrs) |
1.682420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.045900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.149000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.185960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.601800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.131600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.456800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.490600E-01 |
| Normal-vs-Grade 2 |
3.678900E-03 |
| Normal-vs-Grade 3 |
2.64080000000888E-06 |
| Normal-vs-Grade 4 |
4.39099867577397E-11 |
| Grade 1-vs-Grade 2 |
8.100000E-01 |
| Grade 1-vs-Grade 3 |
2.617000E-01 |
| Grade 1-vs-Grade 4 |
8.185900E-04 |
| Grade 2-vs-Grade 3 |
1.429550E-02 |
| Grade 2-vs-Grade 4 |
2.18819995456698E-09 |
| Grade 3-vs-Grade 4 |
1.229960E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.008840E-01 |
| Normal-vs-ccB subtype |
1.97820004821381E-09 |
| ccA subtype-vs-ccB subtype |
4.08519995609424E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.953110E-04 |
| Normal-vs-N1 |
1.70064999999164E-05 |
| N0-vs-N1 |
1.191730E-02 |
|
|
